3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Conditions
COVID-19
4
Neoplasms
2
Rheumatic Diseases
1
Papillomavirus Infections
1
Nervous System Diseases
1
Lung Neoplasms
1
Hematologic Diseases
1
Interventions
Oncolytic Virotherapy
2
Cancer Vaccines
2
Adjuvants, Immunologic
2
pembrolizumab
1
pamiparib
1
interferon gamma-1b
1
glutathione pegylated liposomal doxorubicin
1
Trastuzumab
1
Telemedicine
1
Radiation
1
Plasma Exchange
1
Mycophenolic Acid
1
Interferon-gamma
1
Immunotherapy
1
COVID-19 Vaccines
1
Azathioprine
1
Antibodies, Monoclonal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Nervous System Diseases
×
COVID-19 Vaccines
×
Clear all
NCT04848493
2025-06-13
VAX4FRAIL
Azienda USL Reggio Emilia - IRCCS
Completed
747 enrolled